Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
The group focuses on treatment, research, policy and education around HIV and hepatitis C.
60 groups sign a letter to state insurance commissioners and attorneys general asking them to reverse the policy.
The update includes a new combination therapy that can treat all six genotypes of HCV, a new HIV medication and PrEP.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.